Overview
Heart health is vital to overall wellness.

According to the American College of Cardiology, the percentage of people under 40 having heart attacks has risen two percent a year, year over year, for the past 10 years (American College of Cardiology’s 68th Annual Scientific Session, 2019). Embracing hearth health habits start with nutrition and exercise which are two essential aspects to support cardiovascular and circulatory health. However, our modern busy and sedentary lifestyle paired with poor eating habits make hard to maintain optimal levels of some cardiovascular parameters such as cholesterol and triglyceride profile as well as a healthy inflammatory response.

Researched and developed by Giellepi, ROSSOPURO® Forte is a proprietary synergistic blend consisting of natural origin fermented yeast rice, gamma oryzanol and gamma aminobutyric acid designed for reaching a new level of heart health.

ROSSOPURO® Forte allows for greater formulation flexibility giving product developers the possibility to add in the final formula other beneficial ingredients.

Active:
Total Monacolin K (NLT 3% by HPLC) and total Monacolins (NMT 4.5% by HPLC); Gamma oryzanol, Gamma Aminobutyric Acid.

Form:
Granulated powder

Recommended daily dosage:
65 mg

Applications:
Tablets, capsules, powders (for oral suspension)

Composition

ROSSOPURO® Forte is crafted with care in small batches by fermentation of a yeast called Monascus purpureous. Our standardized fermentation conditions naturally enrich the rice with substances known as monacolins, including Monacolin K. To further enhance the product’s functionality, Gamma Oryzanol (from Oryza sativa L.) and Gamma Aminobutyric Acid (from Zea mays L.) are then added in a specific ratio to the final formula.

Applications

  • People who struggle to follow a proper diet and a regular exercise routine due to a busy lifestyle
  • Healthy consumers who are seeking a healthy remedy to support cardiovascular health
  • Health practitioners who want to offer a natural support to those subjects with borderline levels of cholesterol

Preclinical evidence

In a preclinical efficacy and safety study with mice fed with a high fat diet plus ROSSOPURO® Forte or standard Red Yeast Rice, the bioactive compounds found in ROSSOPURO® Forte were found to work synergistically reducing total cholesterol, LDL-cholesterol, triglycerides and inflammation outperforming standard Red Yeast Rice (Derosa et al. 2019).

Results


Better lipid profile in the group supplemented with ROSSOPURO® Forte

Clinical evidence

The clinical efficacy of ROSSOPURO® Forte has been assessed in a randomized, double blind, placebo controlled trial where 88 adult subjects with borderline total cholesterol (TC) values (i.e., 200–239 mg/dL) and LDL-C values ≤159 mg/dL, equally divided into 2 groups, were supplemented with one capsule per day of active or placebo for 90 consecutive days. ROSSOPURO® Forte resulted in a significant reduction of both TC and LDL-C levels while HDL-C levels were significantly increased. These findings confirm the synergy found in our preclinical study in a mice model of hypercholesterolemia.

Results


Improved lipid profile in subjects supplemented with ROSSOPURO® Forte

Abbreviations: FBG—fasting blood glucose; TC—total cholesterol; LDL-C—low-density lipoprotein cholesterol; HDL-C—high-density lipoprotein cholesterol; TG—triglycerides; CPR—C-reactive protein;

References
Derosa et al. Arch Med Sci 2019; 15 (3): 792–796

Del Lellis et al. Nutrients 2024; 16, 2983

Giellepi solutions

Our legacy of expertise and innovation drives us to create nutritional solutions to support healthy lifestyles.